Table 1.
Demographic Comparisons of the Study Cohort with Respect to Diagnostic Group
| Controls (n=15) | CRSwNP (n=32) | p-value | |
|---|---|---|---|
| n (%) | n (%) | ||
| Gender | |||
| Male | 11 (73.3) | 17 (53.1) | 0.32 |
| Female | 4 (26.7) | 15 (46.9) | |
| Age (average) | 45 | 47 | - |
| Race | |||
| White | 14 (93.3) | 31 (96.9) | 1.00 |
| Non-white | 1 (6.7) | 1 (3.2) | 1.00 |
| Diabetes | 0 (0.0) | 4 (12.5) | 0.38 |
| Asthma | 2 (13.3) | 17 (53.1) | 0.023* |
| Allergy | 4 (26.7) | 21 (65.6) | 0.029* |
| GERD | 5 (33.3) | 12 (37.5) | 1.00 |
| Headache Disorder | 5 (33.3) | 3 (9.4) | 0.15 |
| AERD | 0 (0.0) | 3 (9.4) | 0.56 |
Note: *p<0.05.
Abbreviations: CRSwNP, chronic rhinosinusitis with nasal polyps; GERD, gastroesophageal reflux disease; AERD, aspirin- exacerbated respiratory disease.